The Medicare Access and CHIP Reauthorization Act (MACRA) is the biggest change to how Medicare pays for services in decades. It will accelerate the movement towards value-based payments—where what health care providers get paid depends, at least partially, on the quality of care they provide, not just the volume of services. On June 27, Families USA submitted comments about how the law will be implemented.
Last Wednesday, the Centers for Medicare & Medicaid Services (CMS) released a proposed rule to implement key provisions of the Medicare Access & CHIP Reauthorization Act. Passed with bipartisan support in 2015, MACRA represents is an important opportunity to improve the quality of care delivered through Medicare. Given the number of people who are enrolled in Medicare and the number of providers who see Medicare patients, these changes will have a significant impact throughout the entire health care system.
As drug prices continue to rise at an unsustainable rate, we must ensure that our health care system and its financial incentives enhance the quality and value of care. We believe the Medicare Part B prescription drug model proposed by the Centers for Medicare & Medicaid Services (CMS) creates value for the patient and the program by encouraging treatment choices that have been shown to improve care and health outcomes.
Black History Month inspires us to celebrate the rich history, achievements, and contributions of African Americans in our nation, as well as the hard work that remains to dismantle racism and achieve true racial equality. We agree with Dr. King that fighting injustice in health care is an urgent civil rights issue central to achieving our shared dream of peace, prosperity, and equality for our children. But it is clear that a focus on health care alone will not achieve health equity for African Americans.
Across the country, there is tremendous momentum to change how health care is delivered and paid for in order to improve quality and to curb costs. These initiatives to transform the health system have the potential to improve care for everyone, and could directly address health disparities. Advocates must actively engage in these reform efforts—both to protect communities of color from harm and to take maximum advantage of opportunities to transform health care delivery to better serve people of color.
Through our new Community Health Worker Sustainability Collaborative, launched with the support of the Kresge Foundation, we will work with CHW organizations, health care and health equity advocates, policy makers, and other stakeholders to promote using Medicaid funds to provide more sustainable support to CHW programs and better integrate them into the health care system.
We know that unleashing the power of CHWs in communities across the country will make a tremendous difference in health and health care, especially in communities of color.
2:00 p.m.—We at Families USA have had a blast the past three days. Meeting all of you hard-working advocates has been inspiring and energizing for us. Relive Health Action 2015 by checking out our highlights blog and video of our plenary session on Medicaid and CHIP.
Thanks for being a part of our 20th annual gathering in Washington, D.C., hope to see you next year!
Almost everyone will be faced with the need to make a critical decision about treatment for a disease or medical condition at some point in our lives. If you’re diagnosed with diabetes or heart disease, for example, you’ll want to make sure that you get the best care possible. In that moment, many will ask: What’s the right treatment option for me?
The answer to that question may not be as simple as we might like or expect. Medical evidence is the foundation for determining what works and for whom in health care and informing decision making.
Recent actions by the Center for Medicare and Medicaid Services (CMS) represent an encouraging recognition–by one of the biggest payers of health care in the nation—that one-size-fits all payment reforms do not benefit everyone equally.
And they raise the question of whether some of these pay-for-performance programs should be adjusted to better address racial and ethnic health disparities.